Sam Chun Dang Pharm Balance Sheet Health
Financial Health criteria checks 5/6
Sam Chun Dang Pharm has a total shareholder equity of ₩298.5B and total debt of ₩48.2B, which brings its debt-to-equity ratio to 16.2%. Its total assets and total liabilities are ₩408.0B and ₩109.6B respectively. Sam Chun Dang Pharm's EBIT is ₩9.6B making its interest coverage ratio -45.3. It has cash and short-term investments of ₩92.7B.
Key information
16.2%
Debt to equity ratio
₩48.23b
Debt
Interest coverage ratio | -45.3x |
Cash | ₩92.74b |
Equity | ₩298.46b |
Total liabilities | ₩109.56b |
Total assets | ₩408.02b |
Recent financial health updates
Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly
Dec 01Recent updates
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking
Mar 21Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly
Feb 26Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%
Feb 09Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?
Jan 05Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly
Dec 01Financial Position Analysis
Short Term Liabilities: A000250's short term assets (₩163.9B) exceed its short term liabilities (₩58.0B).
Long Term Liabilities: A000250's short term assets (₩163.9B) exceed its long term liabilities (₩51.6B).
Debt to Equity History and Analysis
Debt Level: A000250 has more cash than its total debt.
Reducing Debt: A000250's debt to equity ratio has increased from 9.8% to 16.2% over the past 5 years.
Debt Coverage: A000250's debt is well covered by operating cash flow (48.6%).
Interest Coverage: A000250 earns more interest than it pays, so coverage of interest payments is not a concern.